InterAx Biotech

InterAx aims to revolutionise drug discovery. We assist drug candidate design and selection with our unique and novel Systems Biology platform. This technology is able to predict in vivo effects of drug candidates by analysing complex experimental datasets. We are now looking for PhD-level scientist to establish ML/AI-driven direction to complement our success in Systems Biology/Pharmacology. The project is highly exciting – was funded at EU level, and combines ML/AI with systems biology and computational chemistry to design drugs selectively targeting biological signalling networks. Such drug selectivity in context of complex networks is considered one of the main frontiers in drug development in 21st century.